$0.00
(Market cap
$34 Mln
Revenue (TTM)
$402 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
15.1
-
Debt to Equity
4.4
-
Book Value
$0.3
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
119,433,440
10 Years Aggregate
CFO
$55.64 Mln
EBITDA
$80.07 Mln
Net Profit
$-188.18 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Accuray (ARAY)
| -67.9 | 17.7 | -31.6 | -83.1 | -54.5 | -42.1 | -26.0 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Accuray (ARAY)
| -58.4 | -29.8 | 35.4 | -56.2 | 14.4 | 47.9 | -17.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Accuray (ARAY)
|
0.3 | 33.6 | 402.0 | -49.2 | -3.6 | -80.1 | -- | 0.8 |
| 61.5 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.5 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.5 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.0 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 90.3 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.8 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 178.2 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Accuray (ARAY)
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle... East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. Read more
-
President, CEO & Director
Ms. Suzanne Winter M.B.A.
-
President, CEO & Director
Ms. Suzanne Winter M.B.A.
-
Headquarters
Madison, WI
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Accuray (ARAY)
What is the current share price of Accuray Incorporated (ARAY) Today?
The share price of Accuray Incorporated (ARAY) is $0.26 (NASDAQ) as of 28-Aug-2026 13:35 EDT. Accuray Incorporated (ARAY) has given a return of -54.49% in the last 3 years.
What is the current PB & PE ratio of Accuray Incorporated (ARAY)?
Since, TTM earnings of Accuray Incorporated (ARAY) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-0.64 |
0.76 |
2025 |
-93.77 |
1.84 |
2024 |
-11.83 |
4.08 |
2023 |
-40.01 |
6.92 |
2022 |
-34.11 |
3.43 |
What is the 52 Week High and Low of Accuray Incorporated (ARAY)?
The 52-week high and low of Accuray Incorporated (ARAY) are Rs 2.10 and Rs 0.22 as of 29-Aug-2026.
What is the market cap of Accuray Incorporated (ARAY)?
Accuray Incorporated (ARAY) has a market capitalisation of $ 34 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Accuray Incorporated (ARAY)?
Before investing in Accuray Incorporated (ARAY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.